Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatlc hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies [1] (multiple letters)

M. G. Wyllie, Claus Roehrborn

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1044-1045
Number of pages2
JournalBJU International
Issue number9
Publication statusPublished - Dec 2003

ASJC Scopus subject areas

  • Urology

Cite this